Effectiveness and safety of secukinumab in Chinese patients with plaque psoriasis in a clinical practice setting: a pilot study

Chin Med J (Engl). 2020 Nov 19;133(24):3017-3019. doi: 10.1097/CM9.0000000000001258.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized*
  • China
  • Humans
  • Pilot Projects
  • Psoriasis* / drug therapy
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • secukinumab